A Phase I, Double-Blind, Double-Dummy, Randomised, Placebo- and Positive-Controlled, 3-Way Crossover, Thorough QT/QTc Study to Evaluate the Effect of a Supratherapeutic Single Dose of Methoxyflurane (Penthrox®) on Cardiac Repolarisation in Healthy Male and Female Subjects

Next Previous
Trial Profile

A Phase I, Double-Blind, Double-Dummy, Randomised, Placebo- and Positive-Controlled, 3-Way Crossover, Thorough QT/QTc Study to Evaluate the Effect of a Supratherapeutic Single Dose of Methoxyflurane (Penthrox®) on Cardiac Repolarisation in Healthy Male and Female Subjects

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Methoxyflurane (Primary)
  • Indications Pain
  • Focus Adverse reactions

    • Most Recent Events

    • 17 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top